Nicole Perry - Jun 11, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Vice President - Accounting
Signature
/s/ David Watson, attorney-in-fact for Nicole Perry
Stock symbol
APLS
Transactions as of
Jun 11, 2021
Transactions value $
-$58,355
Form type
4
Date filed
6/15/2021, 04:04 PM
Previous filing
Jun 2, 2021
Next filing
Jul 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $3.2K +1K +20.63% $3.20* 5.85K Jun 11, 2021 Direct
transaction APLS Common Stock Sale -$61.6K -1K -17.1% $61.56 4.85K Jun 11, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -1K -2.84% $0.00 34.2K Jun 11, 2021 Common Stock 1K $3.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 3, 2015 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.